COVID-19 is caused by the coronavirus SARS-CoV-2 that has an affinity for neural tissue.
There are reports of encephalitis, encephalopathy, cranial neuropathy, Guillain-Barrè …

Abstract Introduction Coronavirus Disease-2019 (SARS-CoV-2) started its devastating
trajectory into a global pandemic in Wuhan, China, in December 2019. Ever since, several …

Methods: This study was a systematic review of current evidence conducted in November
2020 to investigate probable late and long-term complications of COVID-19. We performed a …

Background Oxygenation serves as a cornerstone in the treatment of COVID-19, and several
methods have been extensively studied so far. Herein, we aimed to systematically review …

COVID-19 is a severe respiratory disease caused by the newly identified human coronavirus
(HCoV) Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The virus was …

Introduction While COVID-19 pandemic continues to spread worldwide, researchers have
linked patterns of traits to poor disease outcomes. Risk factors for COVID-19 include asthma …

Similar to its predecessors, coronavirus disease 2019 (COVID-19) exhibits neurotrophic
properties, which lead to progression of neurologic sequelae. Besides direct viral invasion to …

BACKGROUND There is recently a concern regarding the reinfection and reactivation of
previously reCoVered coronavirus disease 2019 (CoVID-19) patients. AIM To summarize …

Objective To characterize the clinical features, risk factors, symptom time‐course, and quality
of life implications for parosmia among coronavirus disease (COVID)‐related olfactory …

OBJECTIVE: The novel coronavirus disease-19 (COVID-19) pandemic had intense social
and economic effects. Patients infected with COVID-19 may present with a series of …